JNJ

192.06

-0.32%↓

ABT

126.47

-1.09%↓

MDT

94.35

-1.76%↓

VEEV

291.35

+0.66%↑

A

147.16

+0.91%↑

JNJ

192.06

-0.32%↓

ABT

126.47

-1.09%↓

MDT

94.35

-1.76%↓

VEEV

291.35

+0.66%↑

A

147.16

+0.91%↑

JNJ

192.06

-0.32%↓

ABT

126.47

-1.09%↓

MDT

94.35

-1.76%↓

VEEV

291.35

+0.66%↑

A

147.16

+0.91%↑

JNJ

192.06

-0.32%↓

ABT

126.47

-1.09%↓

MDT

94.35

-1.76%↓

VEEV

291.35

+0.66%↑

A

147.16

+0.91%↑

JNJ

192.06

-0.32%↓

ABT

126.47

-1.09%↓

MDT

94.35

-1.76%↓

VEEV

291.35

+0.66%↑

A

147.16

+0.91%↑

Search

Simulations Plus Inc

Open

SectorHealthcare

17.33 -2.97

Overview

Share price change

24h

Current

Min

17.31

Max

18.24

Key metrics

By Trading Economics

Income

-70M

-67M

Sales

-2.1M

20M

P/E

Sector Avg

48.528

37.461

Dividend yield

0.48

Profit margin

-330.585

Employees

243

EBITDA

-79M

-74M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

-9.19% downside

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.48%

2.33%

Next Earnings

29 Oct 2025

Market Stats

By TradingEconomics

Market Cap

-28M

323M

Previous open

20.3

Previous close

17.33

News Sentiment

By Acuity

38%

62%

133 / 371 Healthcare

Simulations Plus Inc Chart

Past performance is not a reliable indicator of future results.

Related News

22 Oct 2025, 22:47 UTC

Acquisitions, Mergers, Takeovers

Woodside Energy Signs Up Williams as Investor in Louisiana LNG Project -- Update

22 Oct 2025, 22:13 UTC

Acquisitions, Mergers, Takeovers

Woodside Energy Signs Up Williams as Investor in Louisiana LNG Project

22 Oct 2025, 21:20 UTC

Earnings

Correction to IBM 3Q Sales Jump Article

22 Oct 2025, 20:57 UTC

Earnings

SAP Posts Higher 3Q Revenue, Operating Profit

22 Oct 2025, 23:46 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

22 Oct 2025, 23:46 UTC

Market Talk

Nikkei May Decline Amid U.S.-China Trade Tensions -- Market Talk

22 Oct 2025, 23:41 UTC

Market Talk

Gold Extends Pullback on Likely Profit-Taking -- Market Talk

22 Oct 2025, 23:38 UTC

Market Talk

Gold Extends Pullback on Likely Profit-Taking -- Market Talk

22 Oct 2025, 23:15 UTC

Earnings

Tesla Profit Plunges Despite Third-Quarter Rush to Buy EVs -- 4th Update

22 Oct 2025, 22:28 UTC

Market Talk

Alcoa Cautions About Spending More on U.S. Smelters -- Market Talk

22 Oct 2025, 22:02 UTC

Earnings

Tesla Profit Plunges Despite Third-Quarter Rush to Buy EVs -- 3rd Update

22 Oct 2025, 21:59 UTC

Acquisitions, Mergers, Takeovers

Williams Cos.: Entered Into 1.5 Mtpa LNG Offtake Obligation >WMB

22 Oct 2025, 21:58 UTC

Acquisitions, Mergers, Takeovers

Williams Cos. to Buy 10% Interest in Louisiana LNG LLC >WMB

22 Oct 2025, 21:57 UTC

Acquisitions, Mergers, Takeovers

Williams Cos. to Buy 80% Ownership In, Become Operator of Driftwood Pipeline >WMB

22 Oct 2025, 21:56 UTC

Acquisitions, Mergers, Takeovers

Williams Cos.: Strategic Partnership Entered With Woodside Energy to Invest in Louisiana LNG Project >WMB

22 Oct 2025, 21:47 UTC

Acquisitions, Mergers, Takeovers

Woodside: Williams to Assume LNG Offtake Obligations for 10% of Produced Volumes

22 Oct 2025, 21:47 UTC

Earnings

SAP Stock Drops After Earnings. Cloud Revenue Fell Short. -- Barrons.com

22 Oct 2025, 21:47 UTC

Acquisitions, Mergers, Takeovers

Woodside: Williams to Contribute Its Share of Capex for LNG Facility, Pipeline

22 Oct 2025, 21:46 UTC

Acquisitions, Mergers, Takeovers

Woodside Energy Says Williams Deals Worth US$378 Million Including Capital Reimbursement

22 Oct 2025, 21:45 UTC

Acquisitions, Mergers, Takeovers

Woodside Energy to Sell 80% Interest in Driftwood Pipeline Co. to Williams

22 Oct 2025, 21:45 UTC

Acquisitions, Mergers, Takeovers

Woodside Energy to Sell 10% Interest in Louisiana LNG Holding Co. to Williams

22 Oct 2025, 21:28 UTC

Market Talk
Earnings

Correction to Alcoa Tariff Market Talk

22 Oct 2025, 21:25 UTC

Earnings

Wall Street Wonders if Grail's Cancer Test Results Are a True Positive -- Barrons.com

22 Oct 2025, 21:17 UTC

Earnings

Tesla Profit Plunges Despite Third-Quarter Rush to Buy EVs -- 2nd Update

22 Oct 2025, 21:09 UTC

Market Talk
Earnings

Alcoa Says Delivery Fee Covering Tariff Costs -- Market Talk

22 Oct 2025, 21:00 UTC

Market Talk

ESG Roundup: Market Talk

22 Oct 2025, 20:59 UTC

Earnings

SAP Stock Drops After Earnings. Cloud Revenue Fell Short. -- Barrons.com

22 Oct 2025, 20:51 UTC

Earnings

SAP Reports Mixed Earnings. The Stock is Down. -- Barrons.com

22 Oct 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

22 Oct 2025, 20:44 UTC

Earnings

Kaiser Aluminum: For the Full Yr 2025, Now Expects Conversion Rev to Be Flat to Up 5% Yr-Over-Yr and Raises Adjusted EBITDA Outlook to Improve 20% to 25% Yr-Over-Yr >KALU

Peer Comparison

Price change

Simulations Plus Inc Forecast

Price Target

By TipRanks

-9.19% downside

12 Months Forecast

Average 16 USD  -9.19%

High 16 USD

Low 16 USD

Based on 3 Wall Street analysts offering 12 month price targets forSimulations Plus Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

3 ratings

2

Buy

1

Hold

0

Sell

Sentiment

By Acuity

133 / 371 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Simulations Plus Inc

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, and OBESITYsym products. Further, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Additionally, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Furthermore, it offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.
help-icon Live chat